A recent editorial commentary in Hypertension entitled 'The paradigm has shifted to systolic blood pressure' drew attention to a major new perspective on the management of hypertension over the last few years. 1 At first sight there is nothing surprising about patterns of treatment which change in the light of new trials and epidemiological data. In this case however, progress has not been linear, but cyclical. This has an important message for the way in which we derive our recommendations for the future.
There is now persuasive evidence that cardiovascular risk is more closely associated with systolic than diastolic pressure:
2 indeed at any given systolic pressure level, diastolic pressure is inversely related to risk in the over 50s. 3 Recent end-point trials in isolated systolic hypertension have shown with remarkable consistency the benefits of lowering systolic pressure. 4 Bearing in mind that systolic blood pressure has been measurable for over a century, it seems remarkable that its importance should be so under-estimated. History indicates that this is not the case. The present recognition of the importance of systolic blood pressure represents a return to a position which was clear at the beginning of the century as a result of insurance data. This position met with strong clinical resistance on non-epidemiological grounds.
Insurance evidence on systolic blood pressure
The development of the Riva-Rocci cuff in 1896 provided the first method for rapid, reproducible measurements of systolic blood pressure in man. 5 Although Korotkoff's report on the auscultatory method was published in 1905, 6 his method was only recognised in the West much later and took even longer to be generally used. In 1916, Mackenzie could write of obtaining 'a definite and precise figure which most people imagine to be more scientific, as it is supposed to represent systolic blood pressure. Now it does nothing of the sort, for the figure obtained from the armlet differs from that obtained from the pressure taken directly from the artery'. He goes on to comment upon the happy circumstance that physicians were prevented from doing harm, based upon their estimation of blood pressure by the fact that they were practically powerless to influence it. 7 The insurance companies had moved much more quickly. In the United States, by 1909, 22 of 32 companies recommended measuring systolic blood pressure. 8 The following year Fischer refused to insure individuals with systolic pressures above 140 mm Hg on the grounds that systolic hypertension was associated with a three-fold increase in mortality. 8 Clinical practice moved more slowly. Even in 1925, we read in a paper by a British insurance medical officer that 'a considerable proportion of general practitioners do not possess a sphygmomanometer at all and regard it in the actual words of one of our referees as 'all right for the consultant but of no use to the general practitioner'. With regard to diastolic pressure, the difficulties are of course even greater in getting figures of any value. It is only in a small minority that any estimate is given'. 9 Matters do not appear to have been much better in hospital practice. At the same meeting Lord Dawson of Penge in a discussion of normal values described diastolic blood pressure as 'much less widely studied'. 10 Nevertheless the relationship between systolic blood pressure and life expectancy had been well documented in the insurance data by this time (Table 1) . 9, 11 No such information existed for diastolic pressure. Only much later was it possible to demonstrate important, independent relationships between both diastolic and systolic blood pressure and life expectancy in predominantly middle-class, young and middle-age applicants for life insurance. 12, 13 Expert advice and diastolic pressure
It seems strange, therefore that clinicians, as they became interested in the risks of hypertension, began to focus on diastolic blood pressure rather than systolic blood pressure. Nevertheless, this was the case. In 1926, Halls Dally could write that 'records of systolic pressure alone are of comparatively little value' and list 10 reasons why diastolic blood pressure was of great importance. 14 All these reasons were derived from his interpretation of pathophysiology. Diastolic pressure reflected peripheral resistance, the load to which the heart and vasculature was subject and was constant. Systolic blood pressure, on the other hand reflected 'only an intermittent and superadded load'. More direct evidence on the value of diastolic pressure measurement is scanty in Halls Dally's book. The best that he can muster is a hospital series which reported that only two out of 77 patients with a diastolic blood pressure over 135 mm Hg followed from 1914 'were known to be alive' by 1919. No comparison with the prognostic value of systolic blood pressure was made. He goes on to describe two case histories which underline the unreliable nature of pathophysiological reasoning in isolation. One patient with a blood pressure of 210/70 mm Hg was clearly, according to this view more fortunate than a patient with a blood pressure of 180/140 mm Hg, whose arteries were 'constantly kept under stretch' by the elevated diastolic pressure. The emphasis of insurance companies on systolic pressures was not only clinically wrong, it was also in his view commercially foolish since they 'lose valuable business because certain applicants are excluded on systolic readings alone . . . whilst alternatively others are accepted the height of whose diastolic pressure, had it been known at the time would inevitably have led to their prompt rejection'.
Halls Dally was not alone in his view. Two years later, Rolleston, in his Harveian Oration referred to the 'greater stability of the diastolic than of systolic pressure, and therefore its greater diagnostic value'. 15 Curiously, he goes on to emphasise the importance of the 'pulse or differential pressure' without pointing out that this measurement was inversely related to diastolic pressure. Fishberg, writing slightly later is rather more cautious, but the underlying belief is obviously the same. 16 Diastolic blood pressure, we read, 'is of at least equal significance' to systolic pressure. Again, he writes that prognosis was worse with a very high blood pressure 'particularly a high diastolic pressure'. Illogically, he cites May's data (Table 1) , which only relates to systolic pressure in support of the latter statement.
The emphasis on diastolic pressure by such authorities had profound and long-lasting consequences. As effective blood pressure lowering drugs became available, end-point trials were designed which exclusively used diastolic criteria for recruitment. Meta-analyses of these trials focused on the benefits of diastolic pressure reduction and thus tended unwittingly to reinforce the notion that diastolic pressure was the predominant risk in hypertension, 17 despite the fact that by 1971, the Framingham data had demonstrated the greater predictive value of systolic pressure for cardiovascular disease. 18 When the case for systolic blood pressure was made, 19 it was vigorously opposed. 20 Even in 1999, a study of general practitioners in the United Kingdom showed that their focus was still on diastolic blood pressure. Many physicians were sceptical about the significance of systolic blood pressure, especially those who had qualified more than 11 years before.
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Conclusions
The origins of these misleading beliefs can thus readily be traced back to the writings of leading clinicians of the 1920s. The auscultatory method was only slowly entering clinical practice. Diastolic pressure measurement for all but the specialist was a state of the art development which it was felt could not easily be taken up in routine work. For the specialists however, it was a major advance, and its usage must have conferred a degree of professional status. Further, understanding of the pathophysiology of hypertension in man had moved ahead of its measurement. Once the holy grail of ready estimation of diastolic blood pressure had been achieved, authorities were thus able to argue from physiological evidence that diastolic pressure must be the more important, while accepting to varying degrees that high systolic pressures carried a risk, The existence of insurance data confined to systolic hypertension did not necessarily change this point of view. The absence of evidence about diastolic pressure is not synonymous with evidence for a negative and the best medical reasoning is the result of synthesis of evidence from pathophysiology as well as epidemiology and clinical trials. 22 The position of experts such as Halls Dally can be both understood and defended on these grounds. What is perhaps more difficult to defend is the slowness with which medical culture recognised the importance of systolic hypertension and designed trials to evaluate it. When the results were reported, they were unequivocal. 4 As health services face the unprecedented challenges presented by medical advance, perhaps one of the most useful fields of research would be in the understanding of professional conservatism and resistance to change.
